According to letters from the FDA being shared online, the federal regulatory agency blocked shipments of ivermectin from reaching their intended recipients as they came through ports of entry.
“A shipment addressed to you from a foreign country is being held by the post office at the request of the US Food and Drug Administration,” reads one letter shared by attorney Aaron Siri.
The FDA is working with the post office to hold packages containing ivermectin. The FDA could better use its resources to, I don’t know, publicly release the docs submitted by Pfizer to license its mandated liability-free V earlier than 75 years from now! https://t.co/i6eLcqnciX pic.twitter.com/O2d1zgTjAB
— Aaron Siri (@AaronSiriSG) December 13, 2021
According to the letter, the package containing 200 tablets of “Iverheal ivermectin tablets” was intercepted at the JFK Airport Port of Entry on November 9, 2021.
In another letter, the FDA intercepted 300 tablets of “Iverpac12” back in August, which they said were “subject to refusal of admission into the United States and are subject to administrative destruction.”
The FDA is restricting distribution of Ivermectin, via the USPS.@auraxchan
Fuckers. People will still get it. 🖕🏼 pic.twitter.com/epcaFRWvq6
— 💫Queen of Seventeen 1️⃣7️⃣🥃❤️🇺🇲✝️ (@AreYouAwaQe) August 28, 2021
News of the FDA’s collusion with the US Postal Service comes as more people seek the effective drug and other preventative early treatments to remedy Covid-19 symptoms.